Search Results
Advertisement
Your search for Kevin Knopf, MD, MPH, and Charles Bennett, MD, PhD, MPP matches 2 pages
Showing 1 - 2Generic Drug Shortages and Essential Cancer Medicines
Decisions regarding the rationing of chemotherapy are commonplace in many countries around the world—including those where patients must pay for chemotherapy out of pocket—and increasingly so in cancer settings that treat both well-off and socioeconomically disadvantaged patients. However, these...
The Emperor’s New Clothes: Biosimilars and Cost in Oncology
Biosimilars are biologic products similar to the parent (branded) molecule in structure and function—such as erythropoietin and filgrastim (Neupogen).1 To truly bend the cost curve, we want to see a dramatic economic savings achieved as oncology biosimilars for rituximab (Rituxan), trastuzumab...
Advertisement
Advertisement
Apr
Today In Oncology20
Advertisement
© 2024 HSP News Service, L.L.C.
